XBiotech Inc. cotiza a 2.16 USD y tiene una capitalización bursátil de $66M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, su…
| Periodo | 2020-05 | 2020-03 | 2019-11 | 2019-08 |
|---|---|---|---|---|
| Real | — | $-0.28 | $-0.15 | $-0.16 |
| Estimado | $0.06 | $-0.15 | $-0.15 | $-0.15 |
| Sorpresa | — | -86.7% | +0.0% | -6.7% |
| Métrica | XBIT | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -32.5% | -40.4% | +7.9% |
| ROA | -30.3% | -32.0% | +1.7% |
| Current Ratio | 16.01 | 2.84 | +13.17 |
| Debt / Equity | — | 0.28 | — |